We are meeting with renowned experts at #ESMO26 to get their insights on data emerging from the meeting Keep checking back for their updates, coming soon! #MedEd #OncTwitter #MedTwitter

we're delighted to be at #ESMO26! 🌟 It is fantastic to see so many experts from the @net_connectinfo community, both past and present, sharing their latest research here in Madrid! We are proud to support this expert community as they continue to advance research and care in the #NETcancer field #NeuroendocrineTumours #ESMO26 #MedEd #NETCONNECT #Oncology #MedTwitter #OncTwitter @myESMO

➡️ER+/HER2− ESR1-mutant metastatic breast cancer Are the benefits of elacestrant observed in the #EMERALD trial translating into clinical practice? Dr Seth Wander shares his expert insights, drawing on findings from the Komodo–Foundation Medicine real-world analysis Clinical takeaways in this video 📹 Watch the full video & download the infographic for more: cor2ed.com/n-connect/program… This programme is sponsored by Menarini Stemline and is intended for HCPs only. Brought to you by COR2ED Medical Affairs. #MedEd #OncTwitter #MedTwitter #BCSM

We work closely with medical societies and patient advocacy groups to develop medical education that really makes an impact 🤝 These collaborations are so important to us at COR2ED We're proud to showcase all of the collaborations we have across our different programmes at our #ESMO26 booth Come along to Hall 10, Booth 1031, to meet the team and find out more See you there! #MedEd #Oncology @myESMO

📢 #ESMO26 is here; keep a look out for our conference update! In this video, Dr @tnewsomdavis, who will be sharing an update on HER2-directed NSCLC, introduces the medical experts who will be joining us at ESMO ➡️Drs @LizzySmyth1 & @YJanjigianMD: #Gastric/GEJ cancer ➡️ Assoc. Prof. Gerald Prager: #CRC & #PanCan ➡️ Prof. Hong Jae Chon & Assoc. Prof. Lorenza Rimassa: #HCC / #LiverCancer ➡️ Dr Louise Lim: #NSCLC ➡️ Dr @jhaveri_komal: #BreastCancer ➡️ Dr @DrIacovelli: #ProstateCancer & #BladderCancer What will new data mean for clinical practice? 🎬 Keep checking back to see the videos as soon as they’re released to find out: cor2ed.com/n-connect/program… Gastric/GEJ cancer update supported by an Independent Educational Grant from AstraZeneca. In Spain, the information displayed is exclusively directed to Healthcare Professionals empowered to prescribe or dispense medicinal products. Please do not distribute in media, supporting materials or communication channels aimed at the general public. HCC and HER2-directed NSCLC updates are supported by Independent Educational Grants from BeOne and Bayer, respectively. All other updates supported by COR2ED All content is intended for HCPs only #MedEd #OncTwitter #MedTwitter #pcsm #lcsm

Detecting early joint disease in haemophilia A Explore early joint disease, subclinical bleeding, and strategies to prevent irreversible arthropathy Interactive patient case video! 📹 ✅ Make key clinical decisions for your patient ✅ Click on the screen to respond to questions ✅ Open folders in the video to access supplementary information Dr Escuriola will guide you through the case of a young man with severe haemophilia A who 👉 appears clinically stable 👉 reports no recent bleeds 👉 has a normal physical examination Make decisions on joint assessment, imaging, and management strategies to determine whether subclinical joint disease may be present despite the absence of symptoms Access it here ⤵️ cor2ed.com/n-connect/program… For healthcare professionals only. Brought to you by COR2ED Medical Affairs. Initiated and funded by Sobiᵀᴹ. Note: Based on a fictitious patient case. #MedEd #BleedingDisorders #synovitis #haemophilia #raredisease #MedTwitter

New! Accredited video podcast from @BreastCaConnect Watch the full video on our website or listen on Spotify/Apple, then take the accredited assesment to earn #CME credit 🎓 #BCSM #MedEd #OncTwitter

Understand EP-NEC at a glance >> Tap image to expand << ~Educational infographic~ Extrapulmonary neuroendocrine carcinomas (EP-NECs) are aggressive tumours often subject to misdiagnosis and treatment challenges 📜 Expand the image to find out more about: >>> NETs vs. NECs: Key differences in cell differentiation, growth, prognosis, and biomarker expression >>> Diagnostic Gaps: Overcoming misdiagnosis and specialist access barriers >>> DLL3 & T Cell Engagers: Visualising the mechanism of action of T cell engagers and DLL3 as a promising novel therapeutic target >>> Importance of accessing specialist advice and emotional care Developed with expert review from INCA President and CEO of NeuroEndocrine Cancer Australia, Meredith Cummins Download the infographic & find out more: cor2ed.com/n-connect/program… This programme has been sponsored by Boehringer Ingelheim. Brought to you by COR2ED Medical Affairs #MedEd #OncTwitter #MedTwitter

Early diagnosis and management of synovitis in haemophilia >> How to detect early changes to prevent irreversible joint damage in people with haemophilia A An educational video for HCPs 📺 View-download the accompanying slides: cor2ed.com/n-connect/program… Brought to you by COR2ED Medical Affairs in collaboration with Sobi #MedEd #haemophilia #QoL #bleedingdisorders #raredisease #MedTwitter

📣 Come and see us in Madrid at #ESMO26! 📍 Hall 10, Booth 1031 Get your FREE headshot from our professional photographer, and browse our library of high-quality #MedicalEducation programmes 🩺 We work with renowned medical experts to translate the latest science into #clinicalpractice 🧬 Our content spans a wide range of therapy areas 🎙️Formats include podcasts, videos, micro learnings, patient cases, and more ✅ Most of our programmes are endorsed by medical societies and patient advocacy groups See you there! #Oncology #OncTwitter #OncologyNursing #MedTwitter #MedEd @myESMO

Have you registered yet? >> ATTR-CM: Where Clinical Insight Meets Patient Reality Upcoming interactive webinar for HCPs only 🗓️ Monday 19th October ⏰ 14:00 CEST 📍 Online For HCPs only. Developed & funded by Alnylam Switzerland GmbH and organised in collaboration with COR2ED Medical Affairs. This webinar focuses on disease awareness & diagnosis; treatments and specific medicinal products will not be discussed. 🩺 Hosted by cardiologist Dr Philippe Debonnaire (Sint-Jan Hospital, Bruges, Belgium) and ATTR-CM patient advocate Mr Keith Dares (Canada) Conversation topics: ➡️ Recognising the red flags that may indicate ATTR-CM ➡️ Practical approaches & diagnostic tools to support accurate/timely diagnosis ➡️ Identifying barriers to diagnosis ➡️ What HCPs can learn from patient experiences ➡️ Q&A to ask the speakers your questions! 📜 Register now to save your place! engage.cor2ed.com/events/att… #meded #cardiotwitter #medtwitter TTR-INTX-00255 September 2026

Real-world outcomes of elacestrant in ER+/HER2− ESR1-mut metastatic breast cancer >> Findings from the Komodo–Foundation Medicine real-world analysis 📺 A publication snapshot video from Dr Seth Wander Topics: - The evolving ER+/HER2− mBC Tx landscape & impact of ESR1 mutations - Key findings from the pivotal EMERALD trial - How real-world outcomes from the Komodo–Foundation Medicine analysis complement existing evidence This programme is sponsored by Menarini Stemline and is intended for HCPs only. Brought to you by COR2ED Medical Affairs